Nexavar articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2014/07/25 09:08
2014/07/25 09:08
4d
Inc., an Amgen subsidiary (NASDAQ: AMGN), today announced that an investigational Phase 3 trial of Nexavar® (sorafenib) tablets in patients with advanced breast cancer did not meet its primary...
2014/07/25 09:08
2014/07/25 09:08
Latest videos
2014/07/16 03:43
2014/07/16 03:43
13d
... granted to Hyderabad-based Natco Pharma to manufacture an affordable generic version of Nexavar (sorafenib tosylate), a kidney cancer drug patented by German drug major Bayer AG. Mobile...
2014/07/15 20:44
2014/07/15 20:44
14d
The Nexavar issue dates back to March 9, 2012, when the Controller General of Patents, Designs and Trademarks had granted a compulsory licence to Natco in this regard. At that time, the Centre had...
2014/07/10 13:08
2014/07/10 13:08
19d
... carcinoma (HCC) with Child-Pugh Class B cirrhosis in patients who have failed Nexavar (sorafenib) which is the only FDA approved drug for the treatment of hepatocellular...
2014/07/07 13:08
2014/07/07 13:08
22d
Bayer Inc. is pleased to announce the Health Canada approval of Nexavar for the treatment of patients with locally advanced or metastatic, progressive, differentiated thyroid carcinoma (DTC),...
2014/07/02 23:43
2014/07/02 23:43
26d
... protected in India. For example: India issued a compulsory license for the cancer drug Nexavar. The license waived Nexavar’s patent protection and allowed a domestic Indian pharmaceutical...
2014/07/25 09:08
2014/07/25 09:08
Latest from Twitter